Chedid M L, Audibert F, Bona C
C R Acad Hebd Seances Acad Sci D. 1975 Mar 3;280(9):1197-200.
McIntire and al. have observed that a lipopolysaccharide (LPS) extracted from E. coli could be detoxified by succinylation or phtalylation and remained capable of enhancing the immune respose to serum albumins. The data reported here confirm that several LPS preparations after treatment by phtalylation retained their adjuvant activity when injected with bovine serum albumin or influenza vaccine. Yet their toxicity (as measured in adrenalectomized mice) was at least 10 000-fold smaller. Furthermore it was observed that after phtalylation LPS could still induce blastic transformation of murine B-derived lymphocytes. Thus it was possible to dissociate the toxicity of LPS from both its adjuvant and mitogentic activities.
麦金太尔等人观察到,从大肠杆菌中提取的脂多糖(LPS)可通过琥珀酰化或邻苯二甲酰化进行解毒,并且仍能够增强对血清白蛋白的免疫反应。此处报告的数据证实,几种经邻苯二甲酰化处理的LPS制剂在与牛血清白蛋白或流感疫苗一起注射时仍保留其佐剂活性。然而,它们的毒性(在肾上腺切除的小鼠中测量)至少小了10000倍。此外,观察到经邻苯二甲酰化处理后,LPS仍可诱导鼠源B淋巴细胞的母细胞转化。因此,有可能将LPS的毒性与其佐剂活性和促有丝分裂活性分开。